The neuromodulator space has a new player — and it's generating significant interest among providers and patients alike. Letybo (letibotulinumtoxinA-wlbg) received FDA approval in 2023 and has quickly become one of the most talked-about additions to the injectable market. At Beautologie Cosmetic Surgery & Medical Aesthetics in Bakersfield, we now offer Letybo as an option for patients seeking dynamic wrinkle reduction.

What Is Letybo?

Letybo is an FDA-approved botulinum toxin type A injectable for the temporary improvement of moderate to severe glabellar lines (the vertical lines between the eyebrows, often called "11s" or frown lines). It belongs to the same family of neuromodulators as Botox, Dysport, Xeomin, and Jeuveau — but it's the first botulinum toxin developed in South Korea and the first Korean botulinum toxin to gain FDA approval in the United States.

The active ingredient is letibotulinumtoxinA, which works by temporarily blocking acetylcholine release at the neuromuscular junction — relaxing the targeted muscle and reducing the overlying dynamic wrinkle.

How Is Letybo Different From Botox or Dysport?

All FDA-approved neuromodulators work through the same core mechanism, but they differ in formulation, unit dosing, diffusion patterns, and clinical onset. These differences can matter depending on the treatment area and individual anatomy.

Key characteristics of Letybo:

• Onset: Clinical studies report visible improvement typically within 1–3 days — notably faster than some competing products
• Duration: Results last approximately 3–4 months, consistent with other botulinum toxins
• Dosing: Measured in units, but Letybo units are not interchangeable 1:1 with Botox units — your provider will calculate the right dose based on the product's unique potency profile
• Diffusion: Letybo has a precise diffusion pattern that experienced injectors can leverage for targeted muscle relaxation

A phase III clinical trial published in support of Letybo's FDA approval demonstrated that 75.5% of patients achieved a ≥2-grade improvement in glabellar line severity at day 29, meeting the primary endpoint.¹

What Can Letybo Treat?

At the time of FDA approval, Letybo is indicated for glabellar lines. Many providers with extensive neuromodulator experience also use it off-label for other areas of dynamic facial movement — consistent with established clinical practice for all botulinum toxins. Your Beautologie provider will discuss what's appropriate based on your anatomy, goals, and treatment history.

Common areas addressed with neuromodulators generally include:

• Glabellar lines ("11s") — FDA-indicated use for Letybo
• Horizontal forehead lines
• Crow's feet (lateral canthal lines)
• Brow lifting
• Bunny lines (on the nose)
• Lip lines and lip flip
• Chin dimpling
• Neck bands (platysmal bands)

What to Expect During Your Letybo Appointment

A Letybo treatment at Beautologie takes approximately 15–20 minutes. Here's what the process looks like:

1. Consultation and mapping — Your provider reviews your concerns, assesses muscle activity, and maps injection points
2. Skin prep — The treatment area is cleaned
3. Injections — Ultra-fine needles deliver small amounts of Letybo into the targeted muscles; most patients describe this as a slight pinch
4. Aftercare instructions — You'll receive specific guidance on what to avoid in the hours after treatment

No significant downtime is required. Most patients return to normal activities immediately. Minor redness or pinpoint swelling at injection sites typically resolves within minutes to hours.

When Will I See Results?

Many patients notice softening of the treated lines within 24–48 hours, with full results visible at 7–14 days. Follow-up is typically scheduled at 2 weeks to assess outcomes and address any areas that may benefit from a small touch-up.

Results generally last 3–4 months. Regular treatment intervals help train the muscles and can, over time, reduce the severity of wrinkles in the resting state.

Is Letybo Right for Me?

Letybo is a good option to discuss if you:

• Are new to neuromodulators and want to try the latest approved option
• Have had neuromodulator treatments before and are curious how Letybo compares
• Are concerned about glabellar frown lines and want a fast-onset result
• Want an experienced injector to select the best product for your anatomy

Letybo is not recommended for patients with neuromuscular conditions, known hypersensitivity to botulinum toxin products, or active infection at the injection site. Pregnant and breastfeeding patients should not receive any neuromodulator treatment.

Letybo Injections at Beautologie in Bakersfield

Our Bakersfield injection specialists are experienced with the full range of FDA-approved neuromodulators and will help you choose the right product based on your goals, budget, and past results. We serve patients from across Kern County — including Bakersfield, Tehachapi, Ridgecrest, and Delano.

Book Your Letybo Consultation

Ready to explore Letybo? Schedule an injectable consultation at Beautologie to discuss your goals and review all your neuromodulator options.

Book Your Injectable Consultation at Beautologie →

References:

1. U.S. Food & Drug Administration. FDA Approves Letibotulinumtoxin A (Letybo) for Glabellar Lines. https://www.fda.gov
2. American Academy of Dermatology. Botulinum Toxin Injections: Overview. https://www.aad.org